Endothelin-2 and Its Association with Uric Acid Levels and Systemic Inflammation: Relevance to Chronic Kidney Disease Progression
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27010540 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Alexander Bozhidarov Blazhev und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Medical University-Pleven, 1 Kliment Ohridski Str., 5800 Pleven, Bulgaria. Hauptthemen laut MEDLINE: Uric Acid, Renal Insufficiency, Chronic, Inflammation, Endothelin-2. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Bulgarian Ministry of Education and Science, Bulgarian Ministry of Education and Science under the National Program “Young Scientists and Postdoctoral Students–2”.
Abstract (Originalsprache)
Chronic kidney disease (CKD) is associated with chronic inflammation and metabolic dysregulation. While endothelin-1 (ET-1) has been extensively studied, the role of endothelin-2 (ET-2) in CKD remains poorly understood. This cross-sectional study included 76 participants, 12 healthy controls and 64 CKD patients, stratified into three groups based on estimated glomerular filtration rate (eGFR): Group 1 (eGFR ≥ 90 mL/min/1.73 m2), Group 2 (eGFR 45–89 mL/min/1.73 m2), and Group 3 (eGFR 15–44 mL/min/1.73 m2). Serum concentrations of ET-1, ET-2, ET-3, uric acid (UA), and inflammatory markers (hsCRP and IL-6) were measured. ET-2 levels were significantly higher in the advanced CKD group (median 24.49 pg/mL) compared to controls (median 19.32 pg/mL; p = 0.030). No significant differences were observed for ET-1 or ET-3 across groups. ET-2 levels positively correlated with UA (rho = 0.243, p = 0.036), hsCRP (rho = 0.241, p = 0.039), and IL-6 (rho = 0.244, p = 0.038). These findings suggest that ET-2 may represent a potential biomarker reflecting metabolic and inflammatory dysregulation in CKD and highlight its possible relevance in disease severity assessment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, Medical University-Pleven, 1 Kliment Ohridski Str., 5800 Pleven, Bulgaria.
- Department of Physiology and Pathophysiology, Medical University-Pleven, 1 Kliment Ohridski Str., 5800 Pleven, Bulgaria.
- Hemodialysis Unit, St. Marina Hospital, 5800 Pleven, Bulgaria.
- Department of Clinical Laboratory, Allergology and Clinical Immunology, Medical University-Pleven, 5800 Pleven, Bulgaria.
ORCID-Profile: Alexander Bozhidarov Blazhev, Krasimir Kostov, Borislav Ivanov Ignatov, Tatyana Nedkova Simeonova, Svetla Ognyanova Blazheva
Förderung
- Bulgarian Ministry of Education and Science
- Bulgarian Ministry of Education and Science under the National Program “Young Scientists and Postdoctoral Students–2”
Zitieren
APA
Blazhev, A. B., Kostov, K., Ignatov, B. I., Eftimova, T., Simeonova, T. N., & Blazheva, S. O. (2026). Endothelin-2 and Its Association with Uric Acid Levels and Systemic Inflammation: Relevance to Chronic Kidney Disease Progression. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27010540
Vancouver
Blazhev AB, Kostov K, Ignatov BI, Eftimova T, Simeonova TN, Blazheva SO. Endothelin-2 and Its Association with Uric Acid Levels and Systemic Inflammation: Relevance to Chronic Kidney Disease Progression. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27010540
BibTeX
@article{Blazhev2026,
author = {Blazhev, Alexander Bozhidarov and Kostov, Krasimir and Ignatov, Borislav Ivanov and Eftimova, Tsvetelina and Simeonova, Tatyana Nedkova and Blazheva, Svetla Ognyanova},
title = {Endothelin-2 and Its Association with Uric Acid Levels and Systemic Inflammation: Relevance to Chronic Kidney Disease Progression},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27010540}
}
EUVIMED